119 related articles for article (PubMed ID: 15041304)
1. Composite outcomes in renal transplantation using cyclosporine.
Keown PA
Transplant Proc; 2004 Mar; 36(2 Suppl):35S-39S. PubMed ID: 15041304
[No Abstract] [Full Text] [Related]
2. Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients.
Lewis RL; Canafax DM; Pettit KG; DiCesare J; Kaniecki DJ; Arnold RJ; Roberts MS
Transplant Proc; 1996 Aug; 28(4):2214-7. PubMed ID: 8769203
[No Abstract] [Full Text] [Related]
3. Application of cyclosporine in renal transplantation: experience at the University of Padua.
Furian L; Baldan N; Rigotti P
Transplant Proc; 2004 Mar; 36(2 Suppl):148S-151S. PubMed ID: 15041326
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomics of Neoral, a new formulation of cyclosporine, in renal transplantation.
Abella I
Transplant Proc; 1996 Dec; 28(6):3131-4. PubMed ID: 8962213
[No Abstract] [Full Text] [Related]
5. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
[TBL] [Abstract][Full Text] [Related]
6. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression in kidney transplantation in Poland.
Paczek L; Lao M; Durlik M; Szmidt J; Rowinski W
Transplant Proc; 2004 Mar; 36(2 Suppl):173S-176S. PubMed ID: 15041331
[TBL] [Abstract][Full Text] [Related]
8. The costs and outcomes of kidney transplantation according to initial immunosuppressive drug protocol.
Manninen DL; Evans RW
Clin Transpl; 1987; ():269-75. PubMed ID: 3155305
[No Abstract] [Full Text] [Related]
9. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S
Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
[TBL] [Abstract][Full Text] [Related]
10. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.
Medina-Pestana JO; Felipe CR; Park SI; Machado PG; Garcia R; Spinelli G; Silva LA; Santos CF; Tedesco-Silva H
Transplant Proc; 2004 Mar; 36(2 Suppl):74S-79S. PubMed ID: 15041311
[TBL] [Abstract][Full Text] [Related]
11. Two decades of experience with cyclosporine in renal transplantation in Helsinki.
Salmela KT; Kyllönen LE
Transplant Proc; 2004 Mar; 36(2 Suppl):94S-98S. PubMed ID: 15041315
[TBL] [Abstract][Full Text] [Related]
12. Experience with cyclosporine.
Langone AJ; Helderman JH
Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
[No Abstract] [Full Text] [Related]
13. On realistic survival data, Neoral dosage.
Hull AR
Nephrol News Issues; 1996 Jan; 10(1):15-6. PubMed ID: 8709988
[No Abstract] [Full Text] [Related]
14. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
16. The long-term outcome of kidney transplantation in patients under cyclosporine--a developing country experience.
Moosa MR
Clin Transplant; 2004 Jun; 18(3):267-73. PubMed ID: 15142047
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of kidney transplantation with cyclosporin A.
Cogny-Van Weydevelt F; Dandavino R; Langlois S; Boucher A
Transplant Proc; 2000 Mar; 32(2):434-5. PubMed ID: 10715469
[No Abstract] [Full Text] [Related]
18. Experience with cyclosporine.
Sandrini S; Setti G; Bossini N; Zubani R; Cassamali S; Maiorca P; Maffeis R; Portolani N; Bonardelli S; Nodari F; Tardanico R; Corbetta G; Cancarini G
Transplant Proc; 2004 Mar; 36(2 Suppl):152S-157S. PubMed ID: 15041327
[TBL] [Abstract][Full Text] [Related]
19. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.
Salvadori M; Rosati A; Bertoni E; Bock A; Chapman J; Dussol B; Fritsche L; Kliem V; Lebranchu Y; Oppenheimer F; Pohanka E; Tufveson G; Soergel M
Transplant Proc; 2006 May; 38(4):1010-3. PubMed ID: 16757247
[TBL] [Abstract][Full Text] [Related]
20. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Opelz G; Döhler B;
Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
